Table 5.

Unadjusted Hazard Ratio Estimates for All-Cause Mortality for Each Lipid Variable

	Baseline (Time 0), per 1 mg/dL/per per Log Unit* for Triglyceride	3 Mo Post Implantation, per 1 mg/dL/per Log Unit* for Triglyceride	Change From Baseline to 3 Mo Post Implantation, per 1 mg/dL/per Log Unit* for Triglyceride	Recovery† (Binary Variable) at 3 Mo Post Implantation
Cholesterol unadjusted mortality hazard ratios (95% confidence interval)	0.998 (0.991–1.004)	0.983‡ (0.973–0.993)	0.993§ (0.986–0.999)	0.445§ (0.212–0.932)
No. of subjects, No. of events	n=255, events=51	n=134, events=34	n=129, events=34	n=129, events=34
LDL unadjusted mortality hazard ratios (95% confidence interval)	0.995 (0.986–1.004)	0.971‡ (0.954–0.989)	0.983 (0.966–1.001)	0.549 (0.179–1.684)
No. of subjects, No. of events	n=208, events=39	n=80, events=16	n=63, events=13	n=63, events=13
HDL unadjusted mortality hazard ratios (95% confidence interval)	1.013 (0.990–1.036)	0.969 (0.931–1.009)	0.980 (0.952–1.009)	0.853 (0.299–2.437)
No. of subjects, No. of events	n=210, events=39	n=84, events=17	n=67, events=14	n=67, events=14
Triglyceride unadjusted mortality hazard ratios (95% confidence interval)	0.751 (0.398–1.417)	0.672 (0.264–1.711)	0.532 (0.186–1.525)	0.282§ (0.089–0.890)
No. of subjects, No. of events	n=227, events=41	n=86, events=17	n=75, events=15	n=75, events=15

Time 0=date of left ventricular assist device implantation. LDL indicates low-density lipoprotein; and HDL, high-density lipoprotein.

^*Triglyceride log transformed because of positive skew.

^†Recovery’ defined as change from baseline to 3 mo post implantation ≥median change.

^‡P≤0.01;

^§P≤0.05.